Strides Pharma Science Limited (NSE:STAR)
India flag India · Delayed Price · Currency is INR
856.05
-1.60 (-0.19%)
Feb 16, 2026, 11:40 AM IST

Strides Pharma Science Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
79,05261,67572,11425,85831,12175,754
Market Cap Growth
48.60%-14.47%178.88%-16.91%-58.92%162.55%
Enterprise Value
95,68581,72696,19755,45254,82095,516
Last Close Price
857.65666.19307.18111.72135.22328.50
PE Ratio
15.461.72---28.22
Forward PE
12.5913.1826.9722.79-22.19
PS Ratio
1.671.351.850.701.012.29
PB Ratio
2.822.383.481.191.312.69
P/TBV Ratio
5.244.296.752.282.494.52
P/FCF Ratio
-13.9612.37--41.18
P/OCF Ratio
-9.0110.2958.23-15.74
PEG Ratio
-4.384.384.38-0.36
EV/Sales Ratio
2.021.792.471.501.792.88
EV/EBITDA Ratio
10.8810.6317.9116.30-16.07
EV/EBIT Ratio
13.5513.4126.6638.52-22.31
EV/FCF Ratio
-18.5016.50--51.92
Debt / Equity Ratio
0.660.731.221.391.270.83
Debt / EBITDA Ratio
2.102.374.398.10-3.81
Debt / FCF Ratio
-4.254.32--12.77
Net Debt / Equity Ratio
0.580.651.081.231.190.74
Net Debt / EBITDA Ratio
1.902.194.157.84-57.453.49
Net Debt / FCF Ratio
-3.803.82-52.82-7.0811.27
Asset Turnover
-0.770.620.540.440.50
Inventory Turnover
-1.771.681.521.361.43
Quick Ratio
-0.620.550.590.580.52
Current Ratio
-1.201.031.090.991.03
Return on Equity (ROE)
-17.58%-6.78%-10.13%-18.25%9.01%
Return on Assets (ROA)
-6.41%3.62%1.32%-2.12%4.06%
Return on Invested Capital (ROIC)
13.49%11.96%7.90%2.86%-4.69%8.09%
Return on Capital Employed (ROCE)
-17.60%12.20%3.90%-6.70%10.00%
Earnings Yield
6.47%58.26%-0.98%-7.84%-14.79%3.54%
FCF Yield
-7.17%8.08%-1.95%-12.89%2.43%
Dividend Yield
0.47%0.60%0.81%1.34%-0.76%
Payout Ratio
-0.64%---6.67%
Buyback Yield / Dilution
-0.23%-1.12%-1.02%-0.37%-0.04%-0.14%
Total Shareholder Return
0.24%-0.52%-0.21%0.97%-0.04%0.62%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.